CA
NZ
UK
AU
IND
US
Johnson & Johnson (NYSE: JNJ) reached a settlement aimed at efficiently resolving its ongoing talc litigation, committing $5.5 billion to eliminate future risks associated with 76,000 remaining claims. This move follows a favorable ruling from the Multi-District Litigation (MDL) court, confirming that plaintiffs could …
Johnson & Johnson (NYSE: JNJ) reached a settlement aimed at efficiently resolving its ongoing talc litigation, committing $5.5 billion to eliminate future risks associated with 76,000 remaining claims. This move follows a favorable ruling from the Multi-District Litigation (MDL) court, confirming that plaintiffs could …
Keros Therapeutics, Inc. reported a $28.7 million net loss, with a $2.0 million decrease from the prior year, and expects its cash runway to last into 2028. This decrease matters to investors as it indicates the company's ability to manage expenses and extend its …
Genprex, Inc. listed on the Nasdaq exchange, has announced a strategic collaboration with Roche Diagnostics aimed at strengthening its approach to patient selection in clinical studies targeting non‑small cell lung cancer. The joint effort will concentrate on evaluating biomarker candidates that may help identify …
CRISPR Therapeutics AG (NASDAQ: CRSP) posted second‑quarter revenue of $76 million for its CASGEVY therapy, a 151% jump year‑over‑year and 78% rise sequentially. Earnings came in at $-1.28 per share, trailing the $-1.25 consensus. Cash and marketable securities climbed to $2,364.4 million, underscoring a …
Cue Biopharma, Inc. (NASDAQ: CUE) has appointed James Ahlers as its Chief Financial Officer, effective from July 30, 2026. Ahlers, who brings extensive experience in financial leadership within the life sciences sector, is set to receive an annual base salary of $450,000. This change …
Michigan has confirmed the first two fatalities connected to a cyclospora outbreak, raising alarms over foodborne illnesses. Both victims were reported to have existing health conditions, emphasizing the vulnerability of certain populations during health crises. This incident may lead to increased scrutiny on food …
Eikon Therapeutics, Inc. has confirmed two significant board resignations, effective July 31, 2026, as Dr. Leon Chen and Mr. Joshua Wolfe step down from their roles. This leadership transition arrives at a key time for the company, which has grappled with drastic share price …
Embecta Corp. (NASDAQ: EMBC) received a modest boost as its shares rose 1.4% to $3.69 amid news of an impending class action deadline on August 17, 2026. This increase comes following a significant downturn earlier in the year, with EMBC shares down 68.3% year-to-date. …
Fresenius Medical Care AG (OTC: FMCQF) reported second-quarter earnings, revealing an EPS of $0.91, which is below the consensus estimate of $0.99. Shares increased 3.3% to $51.44 in recent trading, capturing investor interest despite the earnings miss. The market capitalization for Fresenius is approximately …
Please wait processing your request...